In cancer cells, glucose is often converted into lactic acid, which is known as the 'Warburg effect'. The reason that cancer cells have a higher rate of aerobic glycolysis, but not oxidative phosphorylation, remains largely unclear. Herein, we proposed an epigenetic mechanism of the Warburg effect. Fructose-1,6-bisphosphatase-1 (FBP1), which functions to antagonize glycolysis was downregulated through NF-kappaB pathway in Ras-transformed NIH3T3 cells. Restoration of FBP1 expression suppressed anchorage-independent growth, indicating the relevance of FBP1 downregulation in carcinogenesis. Indeed, FBP1 was downregulated in gastric carcinomas (Po0.01, n ¼ 22) and gastric cancer cell lines (57%, 4/7). Restoration of FBP1 expression reduced growth and glycolysis in gastric cancer cells. Moreover, FBP1 downregulation was reversed by pharmacological demethylation. Its promoter was hypermethylated in gastric cancer cell lines (57%, 4/7) and gastric carcinomas (33%, 33/ 101). Inhibition of NF-kappaB restored FBP1 expression, partially through demethylation of FBP1 promoter. Notably, Cox regression analysis revealed FBP1 promoter methylation as an independent prognosis predicator for gastric cancer (hazard ratio: 3.60, P ¼ 0.010). In summary, we found that NF-kappaB functions downstream of Ras to promote epigenetic downregulation of FBP1. Promoter methylation of FBP1 can be used as a new biomarker for prognosis prediction of gastric cancer. Such an important epigenetic link between glycolysis and carcinogenesis partly explains the Warburg effect.
Introduction
In mammalian cells, there are two main ways to generate energy in the form of adenosine triphosphate from glucose, oxidative phosphorylation and glycolysis. Oxidative phosphorylation occurs in the mitochondria with carbon dioxide and water as end products, whereas glycolysis from glucose to lactic acid takes place in the cytoplasm. Glycolysis is usually inhibited in the presence of oxygen, which is termed as the Pasteur effect (DeBerardinis et al., 2008a, b) . However, in some pathologic circumstances such as carcinogenesis, glucose will be metabolized into lactic acid instead of carbon dioxide and water even in the presence of oxygen, which is known as the Warburg effect (Warburg, 1956; Gatenby and Gillies, 2004; Deberardinis et al., 2008a, b) .
Several decades ago, Otto Warburg found that tumor cells consume glucose at a surprisingly higher rate than normal cells and most of the glucose-derived carbon were converted into lactate instead of carbon dioxide (Warburg, 1956) . Unfortunately, interest in the relevance of the Warburg effect has only been rekindled until recently after the successful application of the imaging technique positronemission tomography using the glucose analog 18 fluorodeoxyglucose as the tumor tracer. However, the molecular mechanisms underlying the Warburg effect remain largely unclear.
Being the first oncogene isolated from human tumor cells, Ras was believed to be aberrantly activated in the pathogenesis of many cancers (Karnoub and Weinberg, 2008) . Oncogenic Ras-transformed NIH3T3 cells share many characters of human tumor cells and have been widely used as a model system to explore molecular mechanisms of carcinogenesis. Similar to primary tumor cells, cells transformed by oncogenic Ras in vitro are characterized by a higher rate of aerobic glycolysis accompanied by a high concentration of glycolytic enzymes such as pyruvate kinase isoenzyme type M2 (M2-PK) and also high levels of fructose-1,6-bisphosphate (Eigenbrodt et al., 1992; Dang and Semenza, 1999; Mazurek et al., 2001; Christofk et al., 2008) . Fructose-1,6-bisphosphate is one of the most important intermediates in glycolysis and its level is mainly controlled by fructose-6-phosphate kinase and fructose-1,6-bisphosphatase (FBP) (Jurica et al., 1998) .
The upregulation of fructose-6-phosphate kinase in some tumor cells has been proven (Marin-Hernandez et al., 2006) . However, whether the downregulation of FBP contributes to the increased glucose consumption in tumor cells remains unknown. In mammalian cells, there are two isoenzymes of FBP, FBP1 and FBP2. Although the expression of FBP2 is restricted to muscles, FBP1 is more ubiquitously expressed (MarinHernandez et al., 2006) . In this study, we would like to explore whether the aberrant regulation of FBP1 is involved in oncogenic Ras-initiated cellular transformation and human carcinogenesis.
Results

FBP1 was downregulated in Ras-mediated transformation
In order to know whether FBP1 is involved in Rasmediated cellular transformation, FBP1 expression in NIH3T3 cells before and after oncogenic Ras-initiated transformation was determined by real-time quantitative RT-PCR. FBP1 was significantly downregulated in Ras-transformed NIH3T3 cells (left panel in Figure 1a ). Such a downregulation is unlikely the secondary effect of Ras-initiated cellular transformation, as FBP1 expression was also significantly reduced in NIH3T3 cells with transient Ras transfection (right panel in Figure 1a ). The forced expression of exogenous FBP1 suppressed the anchorage-independent growth of Rastransformed NIH3T3 cells (Figure 1b) , confirming the significance of FBP1 downregulation in Ras-mediated transformation. Interestingly, FBP1 promoter contains several consensus binding sites (GGGRNYYYCC) for NF-kappaB, a transcription factor indispensable for Ras-mediated transformation (Finco et al., 1997) , indicating that NF-kappaB activity might be important to Ras-induced FBP1 downregulation. Indeed, Rasinitiated FBP1 downregulation was reversed after the inhibition of NF-kappaB activity by either the chemical inhibitor, BAY11-7085 (Figure 1c) or the genetic suppressor of NF-kappaB, IkB alpha M (Van Antwerp et al., 1996) (Figure 1d ).
FBP1 downregulation was involved in gastric carcinogenesis
Next, FBP1 expression in human carcinomas was determined by real-time RT-PCR. Interestingly, FBP1 was significantly downregulated in gastric carcinomas in comparison with corresponding adjacent non-tumor tissues (Figure 2a) . Such a downregulation could be confirmed with in vitro cultured gastric cancer cell lines. FBP1 expression was downregulated in four out of seven gastric cancer cell lines (AGS, MKN28, MKN45 and SNU1) (Figure 2b; Supplementary Figure 1) . Importantly, restoration of FBP1 expression led to Figure 1a . P-value was calculated using Wilcoxon match pairs test. (b) FBP1 expression in gastric cancer cell lines were determined by conventional RT-PCR. Glyceraldehyde-3-phosphate dehydrogenase was used as the internal control.
Promoter methylation of FBP1 in gastric cancer X Liu et al significant growth inhibition of gastric cancer cell lines (AGS and MKN28, Figures 3a-d) . Meanwhile, the production of lactate after FBP1 expression was significantly reduced, demonstrating the suppression of aerobic glycolysis by FBP1 (Figure 3e ).
Promoter methylation-mediated FBP1 downregulation in gastric cancer In contrast to mouse FBP1, there is a typical CpG Island (CGI) presented around human FBP1 exon 1 (Figure 4a ), indicating that promoter methylation might have a function in FBP1 downregulation in human gastric cancer cell lines. Indeed, FBP1 expression in gastric cancer cell lines was restored after 5-aza-2 0 -deoxycytidine (Aza)-induced pharmacological demethylation (Figure 4b ). Moreover, FBP1 promoter was fully methylated in gastric cancer cell lines without FBP1 expression such as AGS, MKN28, MKN45 and SNU1, but partially or completely unmethylated in cell lines with FBP1 expression such as Kato III, NCI-N87 and SNU16 ( Figure 4c ). The differential methylation of FBP1 promoter in gastric cancer cell lines revealed by methylation-specific PCR (MSP) could be confirmed by high resolution bisulfite genome sequencing (BGS, Figure 4d ), emphasizing the importance of promoter methylation to FBP1 downregulation in gastric cancer.
FBP1 promoter methylation depended on NF-kappaB activation As NF-kappaB functions downstream of Ras pathway to promote FBP1 downregulation in mouse fibroblast cells (Figure 1 ), we reasoned that NF-kappaB might have a function in the epigenetic downregulation of FBP1 in human gastric cancer cells. Indeed, FBP1 expression was restored in MKN28 cells after siRNAmediated knockdown of two major isoforms of NFkappaB, p50/NFKB1 and p65/relA (Figure 5a ; Supplementary Figure 2 ). In addition, FBP1 promoter was partially demethylated after NF-kappaB depletion ( Figure 5b ). P-values were calculated using student's t-test. The asterisk indicates statistical significant difference (Po0.01). The effect of ectopic FBP1 expression on the growth of AGS (c) and MKN28 (d) cells were determined by growth curve analysis. P-values were calculated using repeated measures ANOVA analysis (Po0.01). (e) The effect of ectopic FBP1 expression on glycolysis was determined by the lactate assay. P-values were calculated using Student's t-test. The asterisks indicate statistical significant difference (Po0.01).
Promoter methylation of FBP1 in gastric cancer X Liu et al
As summarized in Table 1 , TNM stage was significantly associated with the survival. The methylation status of FBP1 promoter, as well as the gender and Lauren type, was found to have a marginal association with the survival on the basis of Kaplan-Meier survival and univariate Cox regression analysis (Figure 6a ; Table 1 ). Importantly, the multivariate analysis with the Cox proportional hazard model revealed FBP1 promoter methylation as an independent prognosis predictor for gastric cancer (P ¼ 0.010, hazard ratio: 3.60) ( Figure 6b ; Table 2 ). In addition, TNM stages and the gender were significantly associated with the survival outcome (Table 2) . Therefore, Kaplan-Meier survival analysis was carried out to explore the influence of TNM stages and the gender on the prognosis prediction function of FBP1 promoter methylation. Once adjusted by TNM stages, FBP1 promoter methylation was significantly associated with the survival (P ¼ 0.041, Log-rank test, data not shown). Moreover, FBP1 promoter methylation was significantly associated with the poorer outcome in male patients with gastric cancer, but not female patients (Figures 6c and d) .
Discussion
Aerobic glycolysis is certainly much less efficient than oxidative phosphorylation in the aspect of adenosine triphosphate generation per glucose consumed. However, by producing adenosine triphosphate through aerobic glycolysis rather than oxidative phosphorylation, tumor cells can generate many metabolic intermediates for the biosynthesis of macromolecules that are essential to maintain highly active cell proliferation. Moreover, because of the enhanced production and secretion of lactic acid from tumor cells, the pH value in tumor microenvironment was usually lower (median Promoter methylation of FBP1 in gastric cancer X Liu et al Promoter methylation of FBP1 in gastric cancer X Liu et al 6.9-7.0) than those in normal tissues (7.4-7.5) (Vaupel et al., 1989) . Such an acidic environment is deleterious for non-tumor cells, whereas the tumor cells can either actively regulate their pH i to physiological level or develop the resistance to acidosis-induced apoptosis (Vaupel et al., 1989) . In addition, as tumors grow, the supporting vasculature is often inadequate, leading to the insufficient supply of oxygen in tumor microenvironment (Tannock, 1968) . Under hypoxia, the energy metabolism and growth of normal cells will be substantially impaired, whereas the tumor cells can survive and grow through the metabolic switch from oxidative phosphorylation to oxygen-independent glycolysis. By conferring such grow advantages on tumor cells, the Warburg effect was proposed as a fundamental property of tumor cells (Garber, 2004; DeBerardinis, 2008) . However, how oncogene activation and/or tumor suppressor gene inactivation during malignant transformation can cause Warburg effect is not fully understood. More glucose will be consumed once tumor cells switched the glucose consumption from oxidative phosphorylation to aerobic glycolysis. Glucose is imported into mammalian cells through glucose transporters. The expression of these glucose transporters is controlled by some important players in carcinogenesis, such p53 and NF-kappaB (Schwartzenberg-Bar-Yoseph et al., 2004; Kawauchi et al., 2008) . Deregulation of these important players eventually leads to the upregulation of glucose transporters, allowing the large influx of glucose into tumor cells. In addition to glucose transporters that located in plasma membrane, some glycolytic enzymes are also regulated by genes having important functions in carcinogenesis (Kondoh et al., 2005; Bensaad et al., 2006; Christofk et al., 2008; Ferguson and Rathmell, 2008; Deberardinis et al., 2008a, b) . These enzymes are deregulated, thus contributing to the Warburg effect during cancer development. For instance, hexokinases that catalyze the phosphorylation of glucose into glucose-6-phosphatase, the first rate-limiting step in glycolysis, is upregulated in many tumors (Lee and Pedersen, 2003; Green and Chipuk, 2006; Mathupala et al., 2008; Peng et al., 2008) . The overexpression of hexokinase was found to be associated with poor prognosis and it was proposed that hexokinase could be a novel target for anti-cancer therapy. Furthermore, TP53-induced glycolysis and apoptosis regulator can function downstream of p53 to inhibit glycolysis by inhibiting the activity of 6-phospho-1-kinase and reducing the level of fructose-1,6-biphosphate (Bensaad et al., 2006) . In this study, we proposed another mechanism for the Warburg effect.
FBP1, which functions to reduce the intercellular level of fructose-1,6-biphosphate, was silenced through promoter methylation in gastric cancer in an NF-kappaB dependant manner (Figure 5c ). The ectopic FBP1 expression led to significant growth inhibition of gastric cancer cells (Figure 3 ). Our preliminary results also indicate that restoration of FBP1 expression could induce cell cycle arrest in gastric cancer cells (data not shown). Whether FBP1 can function to regulate DNA damage response in a similar manner with TP53-induced glycolysis and apoptosis regulator remains unexplored.
Importantly, promoter methylation of FBP1 was detected not only in in vitro cultured gastric cancer cell lines, but also in primary gastric carcinoma tissues. In addition, methylation of FBP1 promoter was found to be an independent prognosis predictor for gastric cancer (Table 2) . Unexpectedly, female patients in the cohort used in this study were associated with an unfavorable outcome than male patients (Table 2 ). It could be attributed to the unequal distribution of stage IV cases in the female and male group. There were more stage IV patients in the female group (18/43) than in the male group (10/49) in this cohort. Nevertheless, methylation of FBP1 promoter was significantly associated with the survival after being adjusted by the gender (P ¼ 0.031, Log-rank test, Figures 6c and d) . Particularly, male patients with methylated FBP1 promoter have a significantly shorter survival (Figure 6d ).
NF-kappaB seems to be important for the initiation and/or maintenance of FBP1 promoter methylation in human gastric cancer cells ( Figure 5) . Depletion of the two major isoform of NF-kappaB demethylated FBP1 promoter and restored FBP1 expression in gastric cancer cells. This is consistent with the importance of NF-kappaB to FBP1 downregulation in oncogenic Rastransformed mouse fibroblast cells (Figure 1) . However, murine FBP1 has no CGI, indicating that promoter methylation is unlikely the mechanism responsible for NF-kappaB-dependent FBP1 downregulation in Rastransformed NIH3T3 cells. NF-kappaB could inhibit the transcription of target genes through the interaction with some transcription corepressors such as histone Aarenstrup et al., 2008; Bhat et al., 2008) . HDACs could in turn interact with DNA methyltransferases (DNMTs) such as DNMT1 and DNMT3B (Fuks et al., 2000; Robertson et al., 2000; Rountree et al., 2000) . Therefore, NF-kappaB-initiated transcriptional suppression of FBP1 could eventually be followed by the formation of promoter CGI hypermethylation that stably silence FBP1 expression. NF-kappaB can be activated by oncogenic Ras and is indispensable for oncogenic Ras-initiated transformation (Finco et al., 1997) . However, oncogenic Ras mutations were rare in gastric cancer (Koshiba et al., 1993) . Instead, NF-kappaB could be activated by other factors such as cytokines in chronic inflammatory microenvironment, which is well known to be important to gastric carcinogenesis ( Figure 5c ). In summary, we found that NF-kappaB-dependent promoter methylation led to FBP1 downregulation in gastric carcinogenesis, thus contributing to the Warburg effect. Importantly, methylation of FBP1 promoter could be used as an independent prognosis predictor for gastric cancer.
Materials and methods
Cell lines and tissue samples NIH3T3 cells and gastric cancer cell lines (AGS, Kato III, MKN28, MKN45, NCI-N87, SNU1 and SNU16) were obtained from Cell Bank, RIKEN BioResource Center (Tsukuba, Ibaraki, Japan) and American Type Culture Collection (ATCC, Manassas, VA, USA). Gastric cancer cells were cultured in RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum and incubated at 5% CO 2 , 37 1C and 95% humidity. NIH3T3 cells were cultured in DMEM medium (Invitrogen) supplemented with 10% fetal bovine serum. The plasmid expressing active H-Ras (Q61 L mutant, Upstate, Lake Placid, NY, USA) was transfected into NIH3T3 cells and stable colonies after G418 selection (500 mg/ml, Invitrogen) were pooled as NIH3T3-Ras cells. The transformation of these cells was confirmed by soft agar assay. For plasmid transfection, FuGENE 6 (Roche Applied Science, Mannheim, Germany) was used after the protocol provided. Plasmid expressing IKM (the genetic suppressor of NF-kappaB, IkB alpha Mutant) was provided by the Addgene (Cambridge, MA, USA) (Van Antwerp et al., 1996) . Total RNA was extracted after 48-h transfection. For chemical treatment, chemicals were added directly to culture medium and RNAs were extracted after 48-h incubation.
All primary tissues were obtained from the Endoscopy Centre of the Prince of Wales Hospital, The Chinese University of Hong Kong. All specimens were immediately frozen in liquid nitrogen and stored at À80 1C until further processing. All subjects were given informed consent to obtain the study materials. The study protocol was approved by the Clinical Research Ethics Committee of the Chinese University of Hong Kong.
Pharmacological demethylation
Cells were treated for 72 h with 5 mM 5-aza-2 0 -deoxycytidine (Aza) (Sigma, St Louis, MO, USA), a widely used methyltransferase inhibitor. Aza was replenished every 24 h. An equivalent concentration of the vehicle (DMSO) was used as the control. The cells were then harvested for total RNA and genomic DNA extraction.
SiRNA transfection
Cells were cultured 24 h in a 12-well plate (1.0 Â 10 5 /well) and transfected with siRNA duplxes (SI02662618 for p50/NF-kappaB1 and SI00301672 for p65/RelA, Qiagen, Hilden, Germany) using HiPerfect transfection reagent (Qiagen). Three days later, cells were harvested for RNA and DNA extraction. SiRNA against GFP (SI04380467, Qiagen) was used as the control.
Total RNA and genomic DNA extraction Total RNA and genomic DNA were extracted using Trizol reagent (Invitrogen) following manufacturer's instruction. The concentrations of RNA and DNA were quantified by NanoDrop 1000 (Nanodrop, Wilmington, DE, USA).
RT-PCR and quantitative real-time RT-PCR Reverse transcription reaction was performed using 1 mg of total RNA with High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA). FBP1 expression levels were determined by conventional RT-PCR with GoTaq polymerase (Promega, Madison, WI, USA) and quantitative real-time PCR using SYBR Green Master Mix Kit (Applied Biosystems). Human or mouse glyceraldehyde-3-phosphate dehydrogenase was used as an internal control of RNA integrity. All primers were listed in Supplementary Table 1.
Bisulfite treatment of DNA and methylation analysis Methylation status of FBP1 was determined by MSP and BGS using bisulfite modified genomic DNA as the template (Wang et al., 2009) . Genomic DNA was bisulphite treated with Zymo DNA Modification Kit (Zymo Research, Orange, CA, USA) according to the protocol provided by the manufacturer. MSP was carried out for 40 cycles with annealing temperature at 62 1C, as earlier described (Cheng et al., 2008) . For BGS, PCR products amplified with BGS primers was agarose gel purified and subjected to direct DNA sequencing using ABI PRISM BigDye Terminator Cycle Sequencing Kit in ABI 3100 sequencer (Applied Biosystems). All primers were listed in Supplementary Table 1 .
Construction of FBP1 expression plasmids
The FBP1 expression plasmid was constructed by cloning of the full-length FBP1 open reading frame into mammalian expression vector pcDNA3.1. The full-length FBP1 open reading frame was amplified from normal stomach cDNA using high fidelity PFU DNA polymerase (Invitrogen). The sequence and orientation of the insert were confirmed by DNA sequencing.
Cell growth assay AGS and MKN28 cells transfected with empty pcDNA3.1 or pcDNA3.1-FBP1 were used for monolayer colony formation assay and growth curve analysis. Cells were cultured 24 h in a 12-well plate (1.0 Â 10 5 /well) and transfected with pcDNA3.1-FBP1 or empty pcDNA3.1 using FuGENE 6 (Roche). After 48 h, the transfectants were re-plated in triplicate and cultured for 14-20 days in complete RPMI1640 medium containing G418 (500 mg/ml). Surviving colonies were stained with Gentian Violet after methanol fixation and visible colonies (X50 cells) were counted. The experiments were repeated three times. For growth curve analysis, cells stably transfected with pcDNA3.1-FBP1 or empty pcDNA3.1 were seeded into a 12-well plate and count the number of viable cells every day for 5 days. Soft agar assay was used to study the effect of FBP1 on the anchorage-independent growth of NIH3T3-Ras cells as described earlier (Jin et al., 2006) .
Lactate assay
The production of lactate was analyzed to determine the rate of aerobic glycolysis. The intracellular level of lactate was measured by the colorimetric lactate assay kit (BioVision, Mountain View, CA, USA) according to the protocol provided. Briefly, cells before and after FBP1 expression were incubated lactate assay buffer containing enzyme and lactate probes. The optical densities were then measured at 570 nm wavelength.
Statistical analysis
The difference of FBP1 mRNA expression between tumor and adjacent non-tumor tissues was analyzed by the Wilcoxon matched pairs test. The w 2 tests were used for comparison of patient characteristics and distributions of methylation by vital status. Patients' age (at entry of follow-up) by vital status was compared using t-test. The probability of overall survival was calculated with the Kaplan-Meier method and differences between curves were evaluated with the Log-rank test. Hazard ratios (HRs) of death associated with FBP1 promoter methylation and other predictor variables were estimated from univariate Cox proportional hazards model. Multivariate Cox models were also constructed to estimate the hazard ratio for various parameters including FBP1 promoter methylation, with adjustments of other parameters such as age, gender, Lauren type, differentiation and TNM stage. All analyses were performed using SPSS for Windows, version 14.0, software. P-value o 0.05 was taken to define the statistical significance.
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